Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2009 1
2010 2
2011 2
2012 6
2013 9
2014 18
2015 10
2016 6
2017 10
2018 8
2019 12
2020 17
2021 17
2022 19
2023 18
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Editorial Comment.
Mehrazin R. Mehrazin R. J Urol. 2023 May;209(5):910. doi: 10.1097/JU.0000000000003201.01. Epub 2023 Mar 6. J Urol. 2023. PMID: 36876405 No abstract available.
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.
Salomé B, Sfakianos JP, Ranti D, Daza J, Bieber C, Charap A, Hammer C, Banchereau R, Farkas AM, Ruan DF, Izadmehr S, Geanon D, Kelly G, de Real RM, Lee B, Beaumont KG, Shroff S, Wang YA, Wang YC, Thin TH, Garcia-Barros M, Hegewisch-Solloa E, Mace EM, Wang L, O'Donnell T, Chowell D, Fernandez-Rodriguez R, Skobe M, Taylor N, Kim-Schulze S, Sebra RP, Palmer D, Clancy-Thompson E, Hammond S, Kamphorst AO, Malmberg KJ, Marcenaro E, Romero P, Brody R, Viard M, Yuki Y, Martin M, Carrington M, Mehrazin R, Wiklund P, Mellman I, Mariathasan S, Zhu J, Galsky MD, Bhardwaj N, Horowitz A. Salomé B, et al. Among authors: mehrazin r. Cancer Cell. 2022 Sep 12;40(9):1027-1043.e9. doi: 10.1016/j.ccell.2022.08.005. Cancer Cell. 2022. PMID: 36099881 Free PMC article.
AUTHOR REPLY.
Mehrazin R. Mehrazin R. Urology. 2020 Sep;143:141. doi: 10.1016/j.urology.2020.04.120. Urology. 2020. PMID: 32862942 No abstract available.
Editorial Comment.
Mehrazin R. Mehrazin R. J Urol. 2018 Sep;200(3):534. doi: 10.1016/j.juro.2018.03.167. Epub 2018 Jun 18. J Urol. 2018. PMID: 29913156 No abstract available.
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Galsky MD, Daneshmand S, Izadmehr S, Gonzalez-Kozlova E, Chan KG, Lewis S, Achkar BE, Dorff TB, Cetnar JP, Neil BO, D'Souza A, Mamtani R, Kyriakopoulos C, Jun T, Gogerly-Moragoda M, Brody R, Xie H, Nie K, Kelly G, Horowitz A, Kinoshita Y, Ellis E, Nose Y, Ioannou G, Cabal R, Del Valle DM, Haines GK, Wang L, Mouw KW, Samstein RM, Mehrazin R, Bhardwaj N, Yu M, Zhao Q, Kim-Schulze S, Sebra R, Zhu J, Gnjatic S, Sfakianos J, Pal SK. Galsky MD, et al. Among authors: mehrazin r. Nat Med. 2023 Nov;29(11):2825-2834. doi: 10.1038/s41591-023-02568-1. Epub 2023 Oct 2. Nat Med. 2023. PMID: 37783966 Free PMC article. Clinical Trial.
Management of Atypical Renal Cell Carcinomas.
Liaw BC, Mehrazin R, Baker C, Sfakianos JP, Tsao CK. Liaw BC, et al. Among authors: mehrazin r. Curr Treat Options Oncol. 2017 Sep 14;18(10):61. doi: 10.1007/s11864-017-0501-1. Curr Treat Options Oncol. 2017. PMID: 28913767 Review.
Novel signatures of prostate cancer progression and therapeutic resistance.
Wang J, Ben-David R, Mehrazin R, Yang W, Tewari AK, Kyprianou N. Wang J, et al. Among authors: mehrazin r. Expert Opin Ther Targets. 2023 Jul-Dec;27(12):1195-1206. doi: 10.1080/14728222.2023.2293757. Epub 2023 Dec 30. Expert Opin Ther Targets. 2023. PMID: 38108262 Review.
Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.
Chen TY, Mihalopoulos M, Zuluaga L, Rich J, Ganta T, Mehrazin R, Tsao CK, Tewari A, Gonzalez-Kozlova E, Badani K, Dogra N, Kyprianou N. Chen TY, et al. Among authors: mehrazin r. Int J Mol Sci. 2023 Sep 28;24(19):14713. doi: 10.3390/ijms241914713. Int J Mol Sci. 2023. PMID: 37834162 Free PMC article. Review.
Minimally invasive adrenal surgery: virtue or vice?
Winoker JS, Ahlborn DT, Omidele OO, Fernandez-Ranvier G, Derweesh IH, Mehrazin R. Winoker JS, et al. Among authors: mehrazin r. Future Oncol. 2018 Feb;14(3):267-276. doi: 10.2217/fon-2017-0420. Epub 2018 Jan 18. Future Oncol. 2018. PMID: 29345155 Review.
Emerging surgical treatments for renal cell carcinoma.
Husain FZ, Badani KK, Sfakianos JP, Mehrazin R. Husain FZ, et al. Among authors: mehrazin r. Future Oncol. 2016 Apr;12(7):921-9. doi: 10.2217/fon.15.362. Epub 2016 Feb 19. Future Oncol. 2016. PMID: 26892144 Review.
140 results